In late December, the Information Office of the State Council (SCIO) released a white paper titled the “Medical and Health Services in China.”  I wrote about the paper briefly over at Forbes, where I suggested that the paper itself is a good proxy for the “glass half-full” versus “glass half-empty” conversation many have about what [...]

Running in concert with this week’s JP Morgan Healthcare Conference is the OneMed China Forum III.  You can find previous coverage of the 2012 event here, and a pre-amble to this year’s event here.  Between last year and 2013, what changed was the emphasis on less top-level market analysis and more practical questions about how [...]